GT199900004A - Comprimido de mesilato de trovafloxacino. - Google Patents

Comprimido de mesilato de trovafloxacino.

Info

Publication number
GT199900004A
GT199900004A GT199900004A GT199900004A GT199900004A GT 199900004 A GT199900004 A GT 199900004A GT 199900004 A GT199900004 A GT 199900004A GT 199900004 A GT199900004 A GT 199900004A GT 199900004 A GT199900004 A GT 199900004A
Authority
GT
Guatemala
Prior art keywords
trovafloxacino
mesylate tablet
compositions
mesylate
tablet
Prior art date
Application number
GT199900004A
Other languages
English (en)
Inventor
Dale Johnson Alton
Christopher Michael Sinko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199900004A publication Critical patent/GT199900004A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

COMPOSICIONES, ESPECIALMENTE EN FORMA DE COMPRIMIDOS, QUE CONTIENEN LA FORMA POLIMORFO II DEL MESILATO DE TROVAFLOXACINO, UN LUBRICANTE, Y CELULOSA MICROCRISTALINA (MC) COMO DILUYENTE. TALES COMPOSICIONES QUE EMPLEAN MC COMO DILUYENTES PRESENTAN BUENAS PROPIEDADES DE ESTABILIDAD DURANTE EL ALMACENAMIENTO Y DE DISOLUCION. ESTOS COMPUESTOS SE RELACIONAN CON LA ESTRUCTURA QUIMICA I, DESCRITA EN EL EXPEDIENTE.
GT199900004A 1998-01-21 1999-01-15 Comprimido de mesilato de trovafloxacino. GT199900004A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
GT199900004A true GT199900004A (es) 2000-07-08

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900004A GT199900004A (es) 1998-01-21 1999-01-15 Comprimido de mesilato de trovafloxacino.

Country Status (34)

Country Link
US (1) US6187341B1 (es)
EP (1) EP0930068A3 (es)
JP (1) JPH11269072A (es)
KR (1) KR100314977B1 (es)
CN (1) CN1227743A (es)
AP (1) AP1094A (es)
AR (1) AR012780A1 (es)
AU (1) AU758381B2 (es)
BG (1) BG103106A (es)
BR (1) BR9900116A (es)
CA (1) CA2259698C (es)
CO (1) CO4810225A1 (es)
DZ (1) DZ2712A1 (es)
EA (1) EA003247B1 (es)
GT (1) GT199900004A (es)
HR (1) HRP990023A2 (es)
HU (1) HUP9900154A3 (es)
ID (1) ID23735A (es)
IL (1) IL128051A0 (es)
IS (1) IS4947A (es)
MA (1) MA24747A1 (es)
NO (1) NO990243L (es)
NZ (1) NZ333838A (es)
OA (1) OA10958A (es)
PA (1) PA8466701A1 (es)
PE (1) PE20000169A1 (es)
PL (1) PL330981A1 (es)
SG (1) SG70666A1 (es)
SK (1) SK4299A3 (es)
TN (1) TNSN99007A1 (es)
TR (1) TR199900089A3 (es)
TW (1) TW518224B (es)
YU (1) YU2399A (es)
ZA (1) ZA99393B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610327B1 (en) * 1998-11-10 2003-08-26 Bayer Aktiengesellschaft Pharmaceutical moxifloxacin preparation
EP1216058A2 (en) * 1999-09-20 2002-06-26 Alza Corporation Process for lessening polymorphic conversion of a drug
JP4803935B2 (ja) * 1999-10-08 2011-10-26 アフィニアム・ファーマシューティカルズ・インコーポレイテッド Ｆａｂｉ阻害剤
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
EP1560584B1 (en) * 2001-04-06 2009-01-14 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1396263A1 (en) 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
JP4880448B2 (ja) 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ，インコーポレーテッド 複数の抗生物質を含む組成物、及びそれを用いる方法
ES2297067T3 (es) * 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
WO2005009395A2 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
WO2007053131A2 (en) 2004-06-04 2007-05-10 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as antibiotic agents
ES2531735T3 (es) * 2004-10-15 2015-03-18 Supernus Pharmaceuticals, Inc. Preparaciones farmacéuticas con menor potencial de abuso
US20090156578A1 (en) * 2005-12-05 2009-06-18 PAULS Henry 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
CA2658506C (en) 2006-07-20 2016-01-26 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab 1 inhibitors
US8263613B2 (en) * 2007-02-16 2012-09-11 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab I inhibitors
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
LT3419628T (lt) 2016-02-26 2021-01-25 Debiopharm International Sa Medikamentas diabetinėms pėdų infekcijoms gydyti

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
WO1997007800A1 (en) * 1995-08-29 1997-03-06 Pfizer Inc. Zwitterionic forms of trovafloxacin

Also Published As

Publication number Publication date
EP0930068A2 (en) 1999-07-21
IS4947A (is) 1999-07-22
HUP9900154A3 (en) 2000-12-28
HRP990023A2 (en) 1999-08-31
TR199900089A2 (xx) 1999-10-21
OA10958A (en) 2001-10-31
MA24747A1 (fr) 1999-10-01
YU2399A (sh) 2002-06-19
NO990243L (no) 1999-07-22
EA003247B1 (ru) 2003-02-27
BR9900116A (pt) 2000-05-02
AU758381B2 (en) 2003-03-20
KR100314977B1 (ko) 2001-11-24
TR199900089A3 (tr) 1999-10-21
AP9901443A0 (en) 1999-03-31
ID23735A (id) 2000-05-11
EA199900046A3 (ru) 1999-12-29
EA199900046A2 (ru) 1999-08-26
HU9900154D0 (en) 1999-03-29
PE20000169A1 (es) 2000-03-10
BG103106A (en) 1999-08-31
PL330981A1 (en) 1999-08-02
KR19990068014A (ko) 1999-08-25
TW518224B (en) 2003-01-21
CA2259698C (en) 2003-04-15
CN1227743A (zh) 1999-09-08
IL128051A0 (en) 1999-11-30
ZA99393B (en) 2000-07-21
SK4299A3 (en) 2000-06-12
CO4810225A1 (es) 1999-06-30
HUP9900154A2 (hu) 1999-09-28
US6187341B1 (en) 2001-02-13
NZ333838A (en) 2000-03-27
JPH11269072A (ja) 1999-10-05
DZ2712A1 (fr) 2003-09-01
AR012780A1 (es) 2000-11-08
AU1217399A (en) 1999-08-12
CA2259698A1 (en) 1999-07-21
NO990243D0 (no) 1999-01-20
PA8466701A1 (es) 2000-09-29
SG70666A1 (en) 2000-02-22
EP0930068A3 (en) 1999-12-22
TNSN99007A1 (fr) 2005-11-10
AP1094A (en) 2002-08-19

Similar Documents

Publication Publication Date Title
GT199900004A (es) Comprimido de mesilato de trovafloxacino.
ATE507212T1 (de) Morpholine als 5ht2c-agonisten
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
AU1192302A (en) Inhibition of emetic effect of metformin with 5-ht3 receptor antagonists
AR054782A2 (es) Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
NO20024339L (no) 1,2,3,4-Tetrahydroisokinolin-derivater
SE7412754L (sv) Dispenser med i forveg fuktade dukar
KR960704531A (ko) 장용성 과립 함유 정제(Enteric Granule-Containing Tablets)
CR20210007A (es) Degradadores selectivos del receptor de estrógeno
ES2165723T3 (es) Composiciones farmaceuticas conteniendo mupirocina.
AR036658A1 (es) Formulacion de dosificacion oral de fundicion instantanea
AR002268A1 (es) Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas.
RU2008142261A (ru) Фармацевтическая композиция с модифицированным высвобождением и ее применение
KR970010764A (ko) 크로몬 유도체, 그의 제조방법 및 의약 조성물
RU2009106483A (ru) Огнезащитный состав
BR9809804A (pt) Piperazinas substituìdas com arila úteis no tratamento de hiperplasia benigna da próstata
ECSP992822A (es) Comprimido de mesilato de trovafloxacina
PE13395A1 (es) Composicion farmaceutica de imidazolil carbazolona
ES377892A1 (es) Procedimiento para la preparacion de 10-piperazino-10,11 - dihidrodibenzo (b, f) tiepinas sustituidas en posicion 8.
UA92218C2 (ru) Способ получения стабильного при хранении биодизельного топлива
ES8305316A1 (es) Un procedimiento para la preparacion de guanidinas.
ES2075688T3 (es) Agente de lavado liquido o pastoso.
MY117392A (en) Monocyclic compounds with four bifunctional residues having nk-2 antagonist action
ECSP982720A (es) Formulacion que contiene un opioide en combinacion con un agonista adrenergico y su utilizacion como analgesico